Monthly Subscription
Unlimited document downloads
$99


Custom Document Search
Locate hard-to-find documents, quickly and inexpensively
$59

See also:

company_intel Lorus Therapeutics Inc.


The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$38
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Code of Business Conduct and Ethics America First Apartment Investors Inc. Lorus Therapeutics Inc.
$51
 Subscribers Subscribers
Preview 		2002
 ContractIntelligence Industrial Lease Hemosol Inc. Lorus Therapeutics Inc.
$38
 Subscribers Subscribers
2004
 ContractIntelligence Lorus Announces Initiation of Phase II Clinical Program for Gti-2501 With Docetaxel in Hormone Refractory Prostate Cancer Lorus Therapeutics Inc.
$38
 Subscribers Subscribers
2004
 ContractIntelligence Lorus Therapeutics Announces Clinical Study to Investigate the Combination of Gti-2040 and Gemcitabine Lorus Therapeutics Inc.
$39
 Subscribers Subscribers
Preview 		2004
 ContractIntelligence Lorus Therapeutics Announces Interim Clinical Results of Gti-2040 In Combination Chemotherapy for the Treatment of Renal Cell Cancer Lorus Therapeutics Inc.
$38
 Subscribers Subscribers
2004
 ContractIntelligence Lorus Therapeutics Inc. Publishes Preclincal Results Describing NC 381, A Lung Cancer Anti-Tumor Agent Lorus Therapeutics Inc.
$38
 Subscribers Subscribers
2004
 ContractIntelligence Lorus Therapeutics Inc. Publishes Results of Synthesis and Characterization of Clotrimazole Analogues as Anticancer Agents Lorus Therapeutics Inc.
$38
 Subscribers Subscribers
2004
 ContractIntelligence Lorus Therapeutics Inc. to Present Results of Virulizin(R) Mechanism Studies at the Asco Gastrointesitinal Cancers Symposium Lorus Therapeutics Inc.
$38
 Subscribers Subscribers
2004
 ContractIntelligence Lorus Therapeutics Participates in 2nd Annual Antisense and Sirna Technologies Conference in London, England Lorus Therapeutics Inc.
$39
 Subscribers Subscribers
Preview 		2003
 Lorus Therapuetics Announces Global Expansion of the Virulizin Registration Phase III Clinical Trial Lorus Therapeutics Inc.
$32
 Subscribers Subscribers
2002
 ContractIntelligence Notification of Late Filing Lorus Therapeutics Inc.
$44
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Registration Rights Agreement Lorus Therapeutics Inc.
$43
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Registration Rights Agreement Conpharm Lorus Therapeutics Inc.
$41
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Registration Rights Agreement America First Apartment Investors Inc. Lorus Therapeutics Inc.
$65
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Share Purchase Agreement Lorus Therapeutics Inc.
$60
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Share Purchase Agreement Conpharm Lorus Therapeutics Inc.
$48
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Share Purchase Agreement America First Apartment Investors Inc. Lorus Therapeutics Inc.
$39
 Subscribers Subscribers
Preview 		2006
 ContractIntelligence Share Purchase Agreement America First Apartment Investors Inc. Lorus Therapeutics Inc.
$40
 Subscribers Subscribers
Preview 		2007
 ContractIntelligence Share Purchase Agreement Lorus Therapeutics Inc.